Recent strategies to develop innovative photosensitizers for enhanced photodynamic therapy

TC Pham, VN Nguyen, Y Choi, S Lee, J Yoon - Chemical reviews, 2021 - ACS Publications
This review presents a robust strategy to design photosensitizers (PSs) for various species.
Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the …

Fluorescent chemical probes for accurate tumor diagnosis and targeting therapy

M Gao, F Yu, C Lv, J Choo, L Chen - Chemical Society Reviews, 2017 - pubs.rsc.org
Surgical resection of solid tumors is currently the gold standard and preferred therapeutic
strategy for cancer. Chemotherapy drugs also make a significant contribution by inhibiting …

An unexpected strategy to alleviate hypoxia limitation of photodynamic therapy by biotinylation of photosensitizers

J An, S Tang, G Hong, W Chen, M Chen, J Song… - Nature …, 2022 - nature.com
The most common working mechanism of photodynamic therapy is based on high-toxicity
singlet oxygen, which is called Type II photodynamic therapy. But it is highly dependent on …

Near-infrared light-initiated molecular superoxide radical generator: rejuvenating photodynamic therapy against hypoxic tumors

M Li, J Xia, R Tian, J Wang, J Fan, J Du… - Journal of the …, 2018 - ACS Publications
Hypoxia, a quite universal feature in most solid tumors, has been considered as the
“Achilles' heel” of traditional photodynamic therapy (PDT) and substantially impairs the …

Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy

L Huang, S Zhao, F Fang, T Xu, M Lan, J Zhang - Biomaterials, 2021 - Elsevier
Nanocarrier-based drug delivery systems hold impressive promise for biomedical
application because of their excellent water dispersibility, prolonged blood circulation time …

Theranostic fluorescent probes

A Sharma, P Verwilst, M Li, D Ma, N Singh… - Chemical …, 2024 - ACS Publications
The ability to gain spatiotemporal information, and in some cases achieve spatiotemporal
control, in the context of drug delivery makes theranostic fluorescent probes an attractive …

Disulfide bond-driven oxidation-and reduction-responsive prodrug nanoassemblies for cancer therapy

B Sun, C Luo, H Yu, X Zhang, Q Chen, W Yang… - Nano …, 2018 - ACS Publications
Disulfide bonds have been widely used to develop reduction-responsive drug-delivery
systems (DDS) for cancer therapy. We propose that disulfide bonds might be also used as …

A minireview of viscosity-sensitive fluorescent probes: design and biological applications

C Ma, W Sun, L Xu, Y Qian, J Dai, G Zhong… - Journal of Materials …, 2020 - pubs.rsc.org
Microenvironment-related parameters like viscosity, polarity, and pH play important roles in
controlling the physical or chemical behaviors of local molecules, which determine the …

Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone

S Zhou, Q Shang, N Wang, Q Li, A Song… - Journal of Controlled …, 2020 - Elsevier
Chemotherapy sometimes can cause potential tumor-specific T-cell-mediated immune
response via stimulating immunogenic cell death (ICD). However, such immune response is …

Small conjugate-based theranostic agents: an encouraging approach for cancer therapy

R Kumar, WS Shin, K Sunwoo, WY Kim… - Chemical Society …, 2015 - pubs.rsc.org
The advances in genomics, proteomics, and bioinformatics have directed the development
of new anticancer agents to reduce drug abuse and increase safe and specific drug …